Pharmacy management solutions companies TELUS Health and
XD3 Solutions recently agreed to make it easier for
pharmacists to switch software providers, in order to resolve the
Competition Bureau's concerns that their proposed merger could
restrict the ability of pharmacist's ability to switch software
TELUS health and XD3 have agreed to include the
following terms in all of its contracts in Quebec for a period of 5
Pharmacists will not be required to obtain TELUS Health's
consent prior to performing a data transfer;
Pharmacists will not be obligated to use TELUS Health's
data transfer tool;
Depending on the pharmacy management platform being used either
pharmacists will be able to provide their new supplier with access
to the TELUS Health platform in order to extract the data or TELUS
Health will, free of charge, provide the customer with a copy of
its data; and
A data transfer fee of up to a maximum of $2,500 may be
charged, only in cases where a pharmacist requests TELUS
Health's assistance with transferring data.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Shareholder disputes are among the most common and complex disputes faced by commercial litigators, in-house counsel and corporate advisors. To achieve the best results for your clients, you must have a comprehensive and up-to-date understanding of the panoply of rights and remedies available to shareholders.
The threshold for certain pre-closing net benefit reviews under the Investment Canada Act (ICA) and the threshold for a pre-closing merger notification under the Competition Act have been increased for 2017.
Regular prices, sale prices, clearance sales – these terms are ubiquitous in the retail world and are a familiar component of marketing strategies intended to convince consumers that now is the best...
The Competition Bureau (the "Bureau") recently released for comment its draft bulletin on Information Requests from Private Parties in Proceedings for Recovery of Loss or Damage (the "Bulletin") which addresses the Bureau's stance on requests for confidential information in its possession arising from private damages actions under section 36 of the Competition Act (the "Act").
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).